Perrigo Reports Fourth Quarter & Fiscal Year 2024 Financial Results From Continuing Operations
Portfolio Pulse from
Perrigo reported its Q4 and fiscal year 2024 financial results, highlighting a fiscal year adjusted EPS of $2.57 and a reported loss of $(1.17) per share. The company saw a 17% increase in infant formula net sales in Q4 due to market share gains and recovering inventory levels. Overall net sales declined by 1.6% due to divestitures, exited product lines, and currency impacts.
February 27, 2025 | 10:30 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Perrigo's fiscal year 2024 results show a mixed performance with adjusted EPS at $2.57 and a reported loss of $(1.17) per share. Q4 infant formula sales grew 17%, but overall net sales declined by 1.6% due to divestitures and currency impacts.
Perrigo's financial results show a stable adjusted EPS, but the reported loss and decline in net sales due to divestitures and currency impacts may concern investors. The growth in infant formula sales is a positive sign, but overall performance is mixed, leading to a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100